ESPR - Esperion Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1221113
Avg. Estimate-1.4-1.36-6.63-5.38
Low Estimate-1.66-1.39-6.96-7.75
High Estimate-1.05-1.32-6.34-1.62
Year Ago EPS-1.44-1.73-6.98-6.63
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts811012
Avg. EstimateN/AN/A10M20.83M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/A100M150M
Year Ago SalesN/AN/AN/A10M
Sales Growth (year/est)N/AN/AN/A108.30%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-1.79-1.56-1.72-1.63
EPS Actual-1.44-1.73-1.71-1.86
Difference0.35-0.170.01-0.23
Surprise %19.60%-10.90%0.60%-14.10%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-1.4-1.36-6.63-5.38
7 Days Ago-1.4-1.36-6.63-5.38
30 Days Ago-1.34-1.31-6.41-5.46
60 Days Ago-1.32-1.31-6.41-5.33
90 Days Ago-1.3-1.31-6.41-5.11
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/A12
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/A11
Growth EstimatesESPRIndustrySectorS&P 500
Current Qtr.2.80%N/AN/A0.48
Next Qtr.21.40%N/AN/A0.40
Current Year5.00%N/AN/A0.21
Next Year18.90%N/AN/A0.10
Next 5 Years (per annum)26.60%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A